Skip to main content

JANE STREET GROUP, LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$190,231 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
11 quarters on record

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Derivatives in NRIX

reported options exposure · as of Jun 30, 2026
CallValue
$1,234,834
CallShares
50,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NRIX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,234,834 50,900
2026-03-31 $190,231 12,273
2025-12-31 $288,344 15,200
2025-12-31 $2,265,093 119,404
2025-12-31 $390,782 20,600
2025-09-30 $2,389,934 258,651
2024-09-30 $3,541,697 157,619
2024-06-30 $4,176,024 200,097
2024-03-31 $833,695 56,714
2023-12-31 $772,368 74,842
2023-09-30 $94,147 11,978
2023-06-30 $386,682 38,707
2022-12-31 $154,082 14,033